The SAGE meeting of 18-20 October 2016 took place at the Centre International de Conférences - Salle 2 in Geneva. Available on this site you will find background reading materials and presentations made at the meeting. The conclusions and recommendations of SAGE meeting are published in the WHO Weekly Epidemiological Record in English and French within two months of each SAGE meeting.
Meeting materials
Related
SAGE Yellow Book - October 2016
SAGE tracking record of recommendations and action points
Ministerial conference on immunization in Africa
Immunization highlights 2015, Report of the WHO Regional Office for Europe
How to respond to vocal vaccine deniers in public. Best practice guidance, EURO
Global report including key updates and challenges from regions-J.M. Okwo-Bele
Global Advisory Committee on Vaccine Safety (GACVS), 15-16 June 2016. WER 2016;91:341-348
Summary of GACVS reviews of HPV vaccines
Report of the Global Advisory Committee on Vaccine Safety (GACVS) - R. Pless
Product Development for Vaccines Advisory Committee (PDVAC)-D. Kaslow
There are no background documents for this session.
SAGE Polio WG - notes from August 2016 meeting
13th Independent Monitoring Board Report
GAPIII Containment Certification Scheme. This document is intended to replace the two pages of Annex 4 of GAPIII: WHO verification that certified poliovirus - essential facilities comply with GAPIII.
Objective of the session and overview of Global Polio Eradication Initiative-M. Zaffran
Measles and Rubella Global Strategic Plan 2012-2020 Midterm Review
Measles and Rubella: Regional Progress Updates
Measles vaccines: WHO position paper. WER 2009;84:349-60
Rubella vaccines: WHO position paper. WER 2011;86:301-16
Background summary, conclusions and recommendations on Hepatitis B containing vaccines
Global burden of HBV-attributable liver cancer
Literature review of the thermostability of hepatitis B containing vaccines
Review of the barriers to implement the birth dose of hepatitis B
Hepatitis B: an updated systematic review of economic evaluations in low and middle income countries
Introduction and key questions for the session - K. Johansen
Conclusions and proposed recommendations for SAGE - K. Johansen
Background paper: Schedules and strategies for human papillomavirus (HPV) immunization
Global burden of cancers attributable to infections in 2012: a synthetic analysis. Lancet Global Health 2016
Modelling estimates of the incremental effectiveness & cost-effectiveness of HPV vaccination
Summary of GACVS reviews of HPV vaccines
Introduction and key questions for the session - A. Pollard
Update on HPV vaccine introduction and programmatic perspective - I. Ogbuanu
Observed and forecast impact of different HPV immunization schedules and strategies - M. Brisson
Conclusions and proposed recommendations for SAGE - A. Pollard
Executive summary: Session on yellow fever vaccines
Global strategy to eliminate yellow fever epidemics (EYE)
Vaccines and vaccination against yellow fever. WHO position paper – June 2013. WER 203;88:269-84
Part 1: Long term Yellow Fever strategy
Epidemiology and risk of yellow fever in current context - O. Tomori
Yellow fever vaccine supply: Projected availability and opportunities for scaling up - A. Costa
Global Strategy for Eliminating Yellow fever Epidemics (EYE) - O. Ronveaux
Part 2: Options for emergency surge capacity
Introduction and context to surge capacity needs - J. Hombach
Feedback from the DRC Yellow fever fractional dose campaign - R. Mihigo
Secretariat recommendations and key research needs - J. Hombach